Mutations specified the fact that, as described down below, CLL therapy is predicated within the presence or absence of those mutations. The current consensus is the fact that, in addition to clonal mutations, subclonal mutations with a variant allelic frequency starting from five to ten% (and so below the brink https://catej544bsj4.frewwebs.com/profile